Clinical Trials Browser

Phase NA × Unknown × Immune Checkpoint Inhibitors × Clear all

NCT05248022 2024-01-09

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05233358 2022-02-10

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular